Vanguard Group Inc Orgenesis Inc. Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.39 - $0.63 $5,796 - $9,363	-14,863 Reduced 1.61%	910,250 $546,000
Q1 2024 May 10, 2024	BUY	$0.28 - $0.9 $85 - $276	307 Added 0.03%	925,113 $758,000
Q4 2022 Feb 10, 2023	BUY	$1.18 - $2.24 $536 - $1,019	455 Added 0.05%	924,806 $1.8 Million
Q1 2022 May 13, 2022	SELL	$2.31 - $3.72 $8,452 - $13,611	-3,659 Reduced 0.39%	924,351 $3.21 Million
Q4 2021 Feb 14, 2022	SELL	$2.61 - $4.9 $3,455 - $6,487	-1,324 Reduced 0.14%	928,010 $2.67 Million
Q2 2021 Aug 13, 2021	BUY	$4.19 - $5.88 $3.89 Million - $5.46 Million	929,334 New	929,334 $4.71 Million

134K

Ticker ORGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,545,800
Market Cap $28.1M
Description
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.